Plain-English translation of NCT06174766 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Read our Hypertension research guide โPhase 3 โ Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This study is testing a new blood pressure medication called HGP2102 to see how well it works and how safe it is in people with essential hypertension (high blood pressure that isn't caused by another condition). Researchers will compare this medication to an existing treatment to understand which approach works better for controlling blood pressure.
Although many blood pressure medications exist, doctors are always looking for new options that may work better, have fewer side effects, or give patients more choices. This trial will help determine whether this new treatment could be a useful option for people whose blood pressure isn't well controlled.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You would visit the clinic multiple times over 10 weeks for blood pressure checks and blood tests. Depending on which group you're assigned to, you'll take the new medication or a comparison treatment once daily by mouth for the entire study period. The study uses a double-blind design, which means neither you nor the study team will know which treatment you're receiving โ this helps ensure fair results.
AI-generated summary from trial data ยท Jun 19, 2026 ยท Not medical advice
South Korea
Phase
Large-scale testing
Sponsor
Hanmi Pharmaceutical Company Limited
Enrollment target
~324 participants
Started
May 2024
Primary completion
December 2026
Age range
19 Years and older
Last updated on clinicaltrials.gov in June 2025.
Reach out to the team running this trial. Response times vary โ some teams are faster than others.
Central contact
Na Young Kim
Hanmi Pharmaceutical Company Limited
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first โ no email needed to get started.